Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells

Journal of Medical Genetics

Volumn 52, Issue 2, 2015, Pages 135-144

  Meng, Xiangning ^a   Qi, Xiuying ^a   Guo, Huanhuan ^a   Cai, Mengdi ^a   Li, Chunxiang ^a   Zhu, Jing ^a   Chen, Feng ^a   Guo, Huan ^a   Li, Jie ^a   Zhao, Yuzhen ^a   Liu, Peng ^a   Jia, Xueyuan ^a   Yu, Jingcui ^a   Zhang, Chunyu ^a   Sun, Wenjing ^a   Yu, Yang ^a   Jin, Yan ^a   Bai, Jing ^a   Wang, Mingrong ^b   Rosales, Jesusa ^c   Lee, Ki Young ^c   Fu, Songbin ^a   more..

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; METHOTREXATE; NON HOMOLOGOUS END JOINING PROTEIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; DNA END JOINING REPAIR; DOUBLE MINUTE CHROMOSOME; DRUG SENSITIVITY; GENE AMPLIFICATION; HT 29 CELL LINE; HUMAN; HUMAN CELL; MICRONUCLEUS; PRIORITY JOURNAL; PROTEIN DEPLETION; SENSITIVITY ANALYSIS; COLONIC NEOPLASMS; DOUBLE STRANDED DNA BREAK; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HT-29 CELL LINE; PATHOLOGY; STAINING;

CELL PROLIFERATION; COLONIC NEOPLASMS; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; HT29 CELLS; HUMANS; METHOTREXATE; STAINING AND LABELING;

EID: 84961323644     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2014-102703     Document Type: Article

References (48)

1. Chatterjee S, Martinez-Lopez W, Grigorova M, Darroudi F, Obe G, Natarajan AT. Comparison of AluI-induced frequencies of dicentrics and translocations in human lymphocytes by chromosome painting. Mutagenesis 1999;14:283-6.
2. Natarajan AT, Boei JJ. Formation of chromosome aberrations: insights from FISH. Mutat Res 2003;544:299-304.
3. Monteilhet C, Perrin A, Thierry A, Colleaux L, Dujon B. Purification and characterization of the in vitro activity of I-Sce I, a novel and highly specific endonuclease encoded by a group I intron. Nucleic Acids Res 1990;18:1407-13.
4. Kuo MT, Vyas RC, Jiang LX, Hittelman WN. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 1994;14:5202-11.
5. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997;89:215-25.
6. Mondello C, Guasconi V, Giulotto E, Nuzzo F. Gamma-ray and hydrogen peroxide induction of gene amplification in hamster cells deficient in DNA double strand break repair. DNA Repair (Amst) 2002;1:483-93.
7. Chakraborty S, Stark JM, Sun CL, Modi H, Chen W, O'Connor TR, Forman SJ, Bhatia S, Bhatia R. Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining. Blood 2012;119:6187-97.
8. Albertson DG. Gene amplification in cancer. Trends Genet 2006;22:447-55.
9. Mc CB. Chromosome organization and genic expression. Cold Spring Harb Symp Quant Biol 1951;16:13-47.
10. Shimizu N. Extrachromosomal double minutes and chromosomal homogeneously staining regions as probes for chromosome research. Cytogenet Genome Res 2009;124:312-26.
11. Pipiras E, Coquelle A, Bieth A, Debatisse M. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 1998;17:325-33.
12. Mondello C, Rebuzzini P, Dolzan M, Edmonson S, Taccioli GE, Giulotto E. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res 2001;61:4520-5.
13. Shen H, Schultz M, Kruh GD, Tew KD. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochim Biophys Acta 1998;1381:131-8.
14. Ader I, Muller C, Bonnet J, Favre G, Cohen-Jonathan E, Salles B, Toulas C. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit. Oncogene 2002;21:6471-9.
15. Cahill D, Connor B, Carney JP. Mechanisms of eukaryotic DNA double strand break repair. Front Biosci 2006;11:1958-76.
16. Okuno Y, Hahn PJ, Gilbert DM. Structure of a palindromic amplicon junction implicates microhomology-mediated end joining as a mechanism of sister chromatid fusion during gene amplification. Nucleic Acids Res 2004;32:749-56.
17. Fenech M. The in vitro micronucleus technique. Mutat Res 2000;455:81-95.
18. Haaf T, Raderschall E, Reddy G, Ward DC, Radding CM, Golub EI. Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol 1999;144:11-20.
19. Shimizu N, Misaka N, Utani K. Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells. Genes Chromosomes Cancer 2007;46:865-74.
20. Singer MJ, Mesner LD, Friedman CL, Trask BJ, Hamlin JL. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc Natl Acad Sci USA 2000;97:7921-6.
21. Morales C, Garcia MJ, Ribas M, Miro R, Munoz M, Caldas C, Peinado MA. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Mol Cancer Ther 2009;8:424-32.
22. Ruiz-Herrera A, Smirnova A, Khouriauli L, Nergadze SG, Mondello C, Giulotto E. Gene amplification in human cells knocked down for RAD54. Genome Integr 2011;2:5.
23. Lo AW, Sabatier L, Fouladi B, Pottier G, Ricoul M, Murnane JP. DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia 2002;4:531-8.
24. Lorico A, Toffoli G, Boiocchi M, Erba E, Broggini M, Rappa G, D'Incalci M. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res 1988;48:2036-41.
25. Toledo F, Buttin G, Debatisse M. The origin of chromosome rearrangements at early stages of AMPD2 gene amplification in Chinese hamster cells. Curr Biol 1993;3:255-64.
26. Ma C, Martin S, Trask B, Hamlin JL. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes Dev 1993;7:605-20.
27. Toledo F, Smith KA, Buttin G, Debatisse M. The evolution of the amplified adenylate deaminase 2 domains in Chinese hamster cells suggests the sequential operation of different mechanisms of DNA amplification. Mutat Res 1992;276:261-73.
28. Debatisse M, Malfoy B. Gene amplification mechanisms. Adv Exp Med Biol 2005;570:343-61.
29. Murnane JP. Telomeres and chromosome instability. DNA Repair (Amst) 2006;5:1082-92.
30. Narayanan V, Lobachev KS. Intrachromosomal gene amplification triggered by hairpin-capped breaks requires homologous recombination and is independent of nonhomologous end-joining. Cell Cycle 2007;6:1814-18.
31. Li YH, Wang X, Pan Y, Lee DH, Chowdhury D, Kimmelman AC. Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response. PLoS ONE 2012;7:e39588.
32. Allen C, Halbrook J, Nickoloff JA. Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res 2003;1:913-20.
33. Neal JA, Dang V, Douglas P, Wold MS, Lees-Miller SP, Meek K. Inhibition of homologous recombination by DNA-dependent protein kinase requires kinase activity, is titratable, and is modulated by autophosphorylation. Mol Cell Biol 2011;31:1719-33.
34. Windle BE, Wahl GM. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat Res 1992;276:199-224.
35. Nonet GH, Carroll SM, DeRose ML, Wahl GM. Molecular dissection of an extrachromosomal amplicon reveals a circular structure consisting of an imperfect inverted duplication. Genomics 1993;15:543-58.
36. Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 1998;2:259-65.
37. Roelofs H, Tasseron-de Jong JG, van der Wal-Aker J, Rodenburg RJ, van Houten GB, van de Putte P, Giphart-Gassler M. Gene amplification in a human osteosarcoma cell line results in the persistence of the original chromosome and the formation of translocation chromosomes. Mutat Res 1992;276:241-60.
38. Storlazzi CT, Fioretos T, Surace C, Lonoce A, Mastrorilli A, Strombeck B, D'Addabbo P, Iacovelli F, Minervini C, Aventin A, Dastugue N, Fonatsch C, Hagemeijer A, Jotterand M, Muhlematter D, Lafage-Pochitaloff M, Nguyen-Khac F, Schoch C, Slovak ML, Smith A, Sole F, Van Roy N, Johansson B, Rocchi M. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 2006;15:933-42.
39. Kloosterman WP, Koster J, Molenaar JJ. Prevalence and clinical implications of chromothripsis in cancer genomes. Curr Opin Oncol 2014;26:64-72.
40. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, Futreal PA, Campbell PJ. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
41. Vogt N, Lefevre SH, Apiou F, Dutrillaux AM, Cor A, Leuraud P, Poupon MF, Dutrillaux B, Debatisse M, Malfoy B. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc Natl Acad Sci USA 2004;101:11368-73.
42. Roth DB, Gellert M. New guardians of the genome. Nature 2000;404:823-5.
43. Yu L, Zhao Y, Quan C, Ji W, Zhu J, Huang Y, Guan R, Sun D, Jin Y, Meng X, Zhang C, Yu Y, Bai J, Sun W, Fu S. Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells. PLoS ONE 2013;8:e71988.
44. Shimizu N. Molecular mechanisms of the origin of micronuclei from extrachromosomal elements. Mutagenesis 2011;26:119-23.
45. Schoenlein PV, Barrett JT, Kulharya A, Dohn MR, Sanchez A, Hou DY, McCoy J. Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes. Int J Radiat Oncol Biol Phys 2003;55:1051-65.
46. Collis SJ, Swartz MJ, Nelson WG, DeWeese TL. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 2003;63:1550-4.
47. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res 2002;62:6400-4.
48. An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC, Zhou PK. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein. Mol Cancer 2008;7:32.